Meeder Asset Management Inc. grew its holdings in shares of Stericycle (NASDAQ:SRCL) by 28.3% in the first quarter, according to its most recent filing with the SEC. The firm owned 12,665 shares of the business services provider’s stock after acquiring an additional 2,794 shares during the quarter. Meeder Asset Management Inc.’s holdings in Stericycle were worth $742,000 as of its most recent SEC filing.
A number of other hedge funds have also made changes to their positions in SRCL. Community Financial Services Group LLC grew its stake in Stericycle by 1.5% in the 4th quarter. Community Financial Services Group LLC now owns 53,975 shares of the business services provider’s stock valued at $3,669,000 after buying an additional 795 shares in the last quarter. California State Teachers Retirement System increased its position in shares of Stericycle by 0.6% in the fourth quarter. California State Teachers Retirement System now owns 138,949 shares of the business services provider’s stock valued at $9,447,000 after buying an additional 815 shares in the last quarter. Armstrong Henry H Associates Inc. increased its position in shares of Stericycle by 6.9% in the fourth quarter. Armstrong Henry H Associates Inc. now owns 12,830 shares of the business services provider’s stock valued at $872,000 after buying an additional 830 shares in the last quarter. Rhumbline Advisers increased its position in Stericycle by 0.6% during the 1st quarter. Rhumbline Advisers now owns 143,833 shares of the business services provider’s stock worth $8,419,000 after purchasing an additional 912 shares in the last quarter. Finally, Amalgamated Bank increased its position in Stericycle by 9.6% during the 4th quarter. Amalgamated Bank now owns 10,442 shares of the business services provider’s stock worth $710,000 after purchasing an additional 918 shares in the last quarter. Institutional investors own 95.63% of the company’s stock.
Shares of NASDAQ:SRCL traded up $0.06 during midday trading on Friday, reaching $63.82. The company had a trading volume of 17,671 shares, compared to its average volume of 1,009,114. The company has a market cap of $5.46 billion, a P/E ratio of 14.71, a P/E/G ratio of 1.43 and a beta of 0.39. The company has a debt-to-equity ratio of 0.88, a quick ratio of 0.81 and a current ratio of 0.81. Stericycle has a 1-year low of $63.36 and a 1-year high of $63.99.
In other Stericycle news, Director Thomas D. Brown sold 13,210 shares of the company’s stock in a transaction on Wednesday, May 16th. The stock was sold at an average price of $63.37, for a total transaction of $837,117.70. Following the completion of the sale, the director now directly owns 14,705 shares in the company, valued at $931,855.85. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Jack W. Schuler bought 10,000 shares of the business’s stock in a transaction on Thursday, March 1st. The shares were acquired at an average price of $62.59 per share, with a total value of $625,900.00. The disclosure for this purchase can be found here. Insiders own 3.50% of the company’s stock.
Several research firms recently commented on SRCL. BidaskClub raised Stericycle from a “sell” rating to a “hold” rating in a research report on Wednesday, January 31st. Barrington Research reissued a “buy” rating on shares of Stericycle in a research report on Monday, February 26th. BMO Capital Markets reissued a “market perform” rating and set a $64.00 price target (down from $72.00) on shares of Stericycle in a research report on Friday, February 23rd. ValuEngine lowered Stericycle from a “hold” rating to a “sell” rating in a research report on Monday, April 2nd. Finally, Robert W. Baird raised Stericycle from an “underperform” rating to a “neutral” rating and set a $73.00 price target on the stock in a research report on Tuesday, February 13th. Two analysts have rated the stock with a sell rating, four have issued a hold rating and five have assigned a buy rating to the stock. The stock has a consensus rating of “Hold” and a consensus target price of $78.63.
Stericycle, Inc, together with its subsidiaries, provides regulated and compliance solutions to the healthcare, retail, and commercial businesses in the United States and internationally. It collects and processes regulated and specialized waste for disposal services; and collects personal and confidential information for secure destruction, as well as offers training, consulting, recall/return, communication, and compliance services.
Receive News & Ratings for Stericycle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle and related companies with MarketBeat.com's FREE daily email newsletter.